Form 4 Tracker
Schrodinger, Inc.
SDGR

34 insider filings · Latest: Sep 17, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 5, 2026Mar 5 8:27 PMLorton Kenneth Patrick
Proposed Sale
1,222$12.90$15.8K—

View →

Mar 5, 2026Mar 5 8:16 PMTran Yvonne
Proposed Sale
1,094$12.89$14.1K—

View →

Mar 5, 2026Mar 5 8:16 PMHerman Jenny
Proposed Sale
775$12.85$10.0K—

View →

Mar 5, 2026Mar 5 8:14 PMFarid Ramy
Proposed Sale
3,661$12.91$47.2K—

View →

Mar 5, 2026Mar 5 8:07 PMJain Rachit
Proposed Sale
1,631$12.90$21.0K—

View →

Mar 5, 2026Mar 5 8:05 PMAkinsanya Karen
Proposed Sale
1,366$12.90$17.6K—

View →

Mar 4, 2026Mar 4 3:21 PMRobert Abel
Proposed Sale
1,300$12.73$16.5K—

View →

Mar 2, 2026Mar 3 9:34 PMRamy FaridDirector, President & CEO
Sale
5,560$11.90$66.2K334,485(D)

View →

Mar 2, 2026Mar 3 9:31 PMKaren AkinsanyaPresident, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships
Sale
2,206$11.99$26.5K71,322(D)

View →

Mar 2, 2026Mar 2 10:06 PMFarid Ramy
Proposed Sale
5,560$11.90$66.2K—

View →

Mar 2, 2026Mar 2 9:35 PMAkinsanya Karen
Proposed Sale
2,206$11.99$26.5K—

View →

Feb 10, 2026Feb 12 9:23 PMYvonne TranEVP, CLO & CPO
Sale
776$13.80$10.7K22,859(D)

View →

Feb 10, 2026Feb 12 9:22 PMKenneth Patrick LortonEVP, CTO & COO, Software
Sale
925$13.73$12.7K52,651(D)

View →

Feb 10, 2026Feb 12 9:21 PMJenny HermanCAO
Sale
752$13.79$10.4K26,597(D)

View →

Feb 9, 2026Feb 11 11:00 PMRobert Lorne AbelEVP, Chief Scientific Officer, Platform
Sale
1,230$13.51$16.6K19,385(D)

View →

Feb 10, 2026Feb 10 8:40 PMHerman Jenny
Proposed Sale
752$13.79$10.4K—

View →

Feb 10, 2026Feb 10 8:35 PMLorton Kenneth Patrick
Proposed Sale
925$13.73$12.7K—

View →

Feb 10, 2026Feb 10 8:29 PMTran Yvonne
Proposed Sale
776$13.80$10.7K—

View →

Feb 9, 2026Feb 9 8:21 PMRobert Abel
Proposed Sale
1,230$13.43$16.5K—

View →

Oct 16, 2025Oct 16 7:16 PMDugan Margaret
Proposed Sale
1,395$21.07$29.4K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 2, 2026Mar 3 9:30 PMRobert Lorne AbelEVP, Chief Scientific Officer, Platform
Grant/Award
34,250$12.1534,250(D)

View →

← Previous

Page 2 of 2